Our vision is to improve the treatment of severe diseases. Working with the medicines of the future we focus on oncology.

Research and Development

Human HealthOasmia is developing the next generation of drugs with focus on oncology.

Further reading »

About Oasmia

Animal HealthOasmia is a pharmaceutical company in Uppsala, Sweden with one approved product in Russia and one conditionally approved in the USA.

Further reading »

The Share

Latest News

Interim report for the period May - July 2016

September 2 2016
Additional market approval for Paclical
Further reading »

Oasmia Pharmaceutical AB Appoints Fredrik Gynnerstedt as Chief Financial Officer

August 31 2016
Further reading »

Notice convening the Annual General Meeting of Shareholders in Oasmia Pharmaceutical AB

August 26 2016
The shareholders of Oasmia Pharmaceutical AB (publ), 556332-6676, are invited to participate in the Annual General Meeting to be held on Monday, September 26, 2016 at 3 p.m. at Vallongatan 1, Uppsala, Sweden. The registration will start at 2.30 p.m.
Further reading »